DK1274709T3 - Salte af bicykliske, N-acylerede imidazo-3-aminer og imidazo-5-aminer - Google Patents

Salte af bicykliske, N-acylerede imidazo-3-aminer og imidazo-5-aminer

Info

Publication number
DK1274709T3
DK1274709T3 DK01931560T DK01931560T DK1274709T3 DK 1274709 T3 DK1274709 T3 DK 1274709T3 DK 01931560 T DK01931560 T DK 01931560T DK 01931560 T DK01931560 T DK 01931560T DK 1274709 T3 DK1274709 T3 DK 1274709T3
Authority
DK
Denmark
Prior art keywords
amines
imidazo
bicyclic
salts
acylated
Prior art date
Application number
DK01931560T
Other languages
English (en)
Inventor
Matthias Gerlach
Corinna Maul
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK1274709T3 publication Critical patent/DK1274709T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
DK01931560T 2000-04-20 2001-04-03 Salte af bicykliske, N-acylerede imidazo-3-aminer og imidazo-5-aminer DK1274709T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10019714A DE10019714A1 (de) 2000-04-20 2000-04-20 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
PCT/EP2001/003772 WO2001081344A1 (de) 2000-04-20 2001-04-03 Salze von bicyclischen, n-acylierten imidazo-3-aminen und imidazo-5-aminen

Publications (1)

Publication Number Publication Date
DK1274709T3 true DK1274709T3 (da) 2004-07-12

Family

ID=7639529

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01931560T DK1274709T3 (da) 2000-04-20 2001-04-03 Salte af bicykliske, N-acylerede imidazo-3-aminer og imidazo-5-aminer

Country Status (30)

Country Link
US (2) US7087607B2 (da)
EP (1) EP1274709B1 (da)
JP (1) JP2003531208A (da)
KR (1) KR100756594B1 (da)
CN (1) CN1232520C (da)
AR (1) AR030559A1 (da)
AT (1) ATE277045T1 (da)
AU (2) AU5830501A (da)
BR (1) BR0110357A (da)
CA (1) CA2402808A1 (da)
CZ (1) CZ20023476A3 (da)
DE (2) DE10019714A1 (da)
DK (1) DK1274709T3 (da)
ES (1) ES2227186T3 (da)
HK (1) HK1052703B (da)
HU (1) HUP0300532A3 (da)
IL (2) IL152352A0 (da)
MX (1) MXPA02009602A (da)
NO (1) NO323542B1 (da)
NZ (1) NZ521069A (da)
PE (1) PE20011213A1 (da)
PL (1) PL365676A1 (da)
PT (1) PT1274709E (da)
RU (1) RU2268888C2 (da)
SI (1) SI1274709T1 (da)
SK (1) SK15022002A3 (da)
TR (1) TR200402755T4 (da)
UY (1) UY26675A1 (da)
WO (1) WO2001081344A1 (da)
ZA (1) ZA200209408B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10019714A1 (de) 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen
DE10050663A1 (de) † 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
MX2007014510A (es) 2005-05-20 2008-02-05 Array Biopharma Inc Compuestos inhibidores de raf y metodos de uso de los mismos.
CA2620223A1 (en) 2005-09-02 2007-03-08 Abbott Laboratories Novel imidazo based heterocycles
AU2006331673B2 (en) 2005-12-23 2013-02-28 Ariad Pharmaceuticals, Inc. Bicyclic heteroaryl compounds
JP4610668B2 (ja) * 2006-03-17 2011-01-12 アムビト ビオスシエンセス コルポラチオン 疾患を治療するためのイミダゾロチアゾール化合物
EA200870592A1 (ru) * 2006-05-31 2009-08-28 Галапагос Н.В. Триазолопиразиновые соединения, пригодные для лечения дегенеративных и воспалительных заболеваний
EP2068869A4 (en) * 2006-10-06 2011-05-25 Abbott Lab NEW IMIDAZOTHIAZOLE AND IMIDAZOXAZOLE
US7985375B2 (en) * 2007-04-06 2011-07-26 Qiagen Gaithersburg, Inc. Sample preparation system and method for processing clinical specimens
US8703492B2 (en) 2007-04-06 2014-04-22 Qiagen Gaithersburg, Inc. Open platform hybrid manual-automated sample processing system
WO2009038757A2 (en) * 2007-09-19 2009-03-26 Ambit Biosciences Corporation Solid forms comprising n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
US9953141B2 (en) 2009-11-18 2018-04-24 Becton, Dickinson And Company Laboratory central control unit method and system
KR200453430Y1 (ko) * 2011-01-10 2011-05-03 백현숙 싱크대용 선반
AU2013251683A1 (en) 2012-04-26 2014-12-18 Bristol-Myers Squibb Company Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
AU2013251680A1 (en) 2012-04-26 2014-11-13 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
SI3243826T1 (sl) 2012-04-26 2020-03-31 Bristol-Myers Squibb Company Derivati imidazotiadiazola in imidazopirazina kot proteazno aktivirani receptor 4 (PAR4) inhibitorji za zdravljenje agregacije trombocitov
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2857776A (en) 1955-01-13 1958-10-28 American Metal Prod Lead screw selectively operable and releasable under load
US3489755A (en) 1966-08-03 1970-01-13 Pfizer & Co C Imidazo (1,2-b) pyridazines
US3792166A (en) * 1970-11-16 1974-02-12 American Cyanamid Co Method of using substituted imidazo (2,1-b)thiazoles as anthelmintic agents
US3894022A (en) * 1973-06-25 1975-07-08 Sandoz Ag Tetracyclic quinazolinones and quinazolinium salts
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation
GB2039882A (en) * 1979-01-05 1980-08-20 Ciba Geigy Ag Bicyclic thiadiaza compounds and their use as medicaments
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
FR2568880B1 (fr) * 1984-08-07 1986-12-12 Synthelabo Derives d'acylaminomethyl-3 imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
FR2627491B1 (fr) * 1988-02-18 1992-01-24 Roussel Uclaf Nouveaux derives du benzocyclohexane et du benzocycloheptane ainsi que leurs sels, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
JPH0753730B2 (ja) * 1988-07-26 1995-06-07 三共株式会社 イミダゾピラゾール誘導体
US5536853A (en) * 1994-04-11 1996-07-16 Chiron Corporation Opiate receptor ligands
DE10019714A1 (de) 2000-04-20 2002-01-10 Gruenenthal Gmbh Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen

Also Published As

Publication number Publication date
HUP0300532A3 (en) 2009-01-28
SK15022002A3 (sk) 2003-04-01
MXPA02009602A (es) 2003-03-10
EP1274709A1 (de) 2003-01-15
WO2001081344A1 (de) 2001-11-01
CA2402808A1 (en) 2001-11-01
JP2003531208A (ja) 2003-10-21
KR100756594B1 (ko) 2007-09-10
NO323542B1 (no) 2007-06-11
ATE277045T1 (de) 2004-10-15
ZA200209408B (en) 2004-02-19
US7087607B2 (en) 2006-08-08
US20060217378A1 (en) 2006-09-28
PT1274709E (pt) 2005-01-31
PE20011213A1 (es) 2001-12-29
DE10019714A1 (de) 2002-01-10
RU2268888C2 (ru) 2006-01-27
CN1232520C (zh) 2005-12-21
AU5830501A (en) 2001-11-07
IL152352A (en) 2009-09-22
HUP0300532A2 (hu) 2003-07-28
NO20024838D0 (no) 2002-10-07
PL365676A1 (en) 2005-01-10
NO20024838L (no) 2002-10-07
US20030119842A1 (en) 2003-06-26
HK1052703A1 (en) 2003-09-26
CN1422270A (zh) 2003-06-04
SI1274709T1 (en) 2005-02-28
AU2001258305B2 (en) 2005-08-18
US7153873B2 (en) 2006-12-26
KR20020087497A (ko) 2002-11-22
NZ521069A (en) 2004-07-30
UY26675A1 (es) 2001-05-31
RU2002130245A (ru) 2004-03-27
TR200402755T4 (tr) 2004-12-21
ES2227186T3 (es) 2005-04-01
CZ20023476A3 (cs) 2003-01-15
HK1052703B (zh) 2005-04-22
IL152352A0 (en) 2003-05-29
EP1274709B1 (de) 2004-09-22
DE50103764D1 (de) 2004-10-28
AR030559A1 (es) 2003-08-27
BR0110357A (pt) 2004-04-20

Similar Documents

Publication Publication Date Title
DK1274709T3 (da) Salte af bicykliske, N-acylerede imidazo-3-aminer og imidazo-5-aminer
DK1438306T3 (da) Derivater af UK-2A
NO20042933L (no) Vekselretter
DE60032736D1 (de) Ringfixateur
DK1432329T3 (da) Tandbörste
DE60105229D1 (de) Laserbehandlungsgerät
DK1337521T3 (da) Salte af en isothiasol-4-carboxamid og deres anvendelse som antihyperproliferationsmiddel
DE60100737D1 (de) Laserbehandlungsgerät
NO20035121D0 (no) Ny anvendelse
DE60229764D1 (de) Entgratwerkzeug
ATE329502T1 (de) Fixiereinlage
DK1408964T3 (da) Hidtil ukendt anvendelse af 2-5-(4-fluorphenyl)-3-pyridylmethylaminomethyl-chroman og fysiologisk acceptable salte deraf
NO20033919D0 (no) Ny anvendelse
DE50212755D1 (de) Bohrfutter
DE10294532D2 (de) Künstlicher Lymphknoten
DE60222567D1 (de) Glutaminase
ITGE20010022V0 (it) Orologio
ES1049328Y (es) Conjunto de llavero
FI20012580A0 (fi) Symmetrinen salausmenetelmä
SE0100813D0 (sv) Uppvärmingsblock
ES1050096Y (es) Llavero identificable
DE50200779D1 (de) Planenhalter
ES1049554Y (es) Agenda de bolsillo
FIU20010270U0 (fi) Hammasharja
FI20012564A0 (fi) Hammasharja